AURORA, Colo., Oct. 28, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking ...
The etiopathogenesis of ankylosing spondylitis (AS) is not fully understood. However, there is strong evidence indicating that genetic factors play a pivotal role in disease susceptibility, and that ...
AURORA, Colo., Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human ...
A debilitating autoimmune condition silently attacks the spine and surrounding joints, causing inflammation that gradually transforms flexible vertebrae into rigid, fused bone. Ankylosing spondylitis ...
The HLA-B27 genetic marker is known to be associated with increased risk for various arthropathies, including JIA. Whether the genetic marker's presence has prognostic value has been uncertain. In ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. AUSTIN, Texas — Research in genetics as it relates to ...
Human leukocyte antigen (HLA) alleles not only increase susceptibility to multiple sclerosis (MS), but also influence the course of the disease, suggests research. The findings, published in JAMA ...
The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients globally living with spinal rigidity, morning stiffness and pain, bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback